Quarterly report pursuant to Section 13 or 15(d)

EQUITY - Summary of Equity Instruments Other than Options (Details)

v3.23.1
EQUITY - Summary of Equity Instruments Other than Options (Details)
 3 Months Ended
Mar. 31, 2023
$ / shares
shares
Nonvested, Number of Shares  
Vested (in shares) (5,952)
Warrants  
Nonvested, Number of Shares  
Issued and outstanding at beginning of period (in shares) 86,048,837
Cancelled (in shares) (100,000)
Issued and outstanding at end of period (in shares) 85,948,837
Weighted - Average Exercise Price  
Issued and outstanding at beginning of period (in dollars per share) | $ / shares $ 1.40
Cancelled (in dollars per share) | $ / shares 1.47
Issued and outstanding at end of period (in dollars per share) | $ / shares $ 1.40
Exercisable  
Nonvested, Number of Shares, Exercisable (in shares) 83,723,837
Weighted - Average Exercise Price, Exercisable (in dollars per share) | $ / shares $ 1.38
Warrants | Non-Derivative (Equity) Warrants  
Nonvested, Number of Shares  
Issued and outstanding at beginning of period (in shares) 30,673,635
Cancelled (in shares) (100,000)
Issued and outstanding at end of period (in shares) 30,573,635
Exercisable  
Nonvested, Number of Shares, Exercisable (in shares) 28,348,635
Warrants | Derivative Liabilities Warrants  
Nonvested, Number of Shares  
Issued and outstanding at beginning of period (in shares) 55,375,202
Cancelled (in shares) 0
Issued and outstanding at end of period (in shares) 55,375,202
Exercisable  
Nonvested, Number of Shares, Exercisable (in shares) 55,375,202
Restricted stock  
Nonvested, Number of Shares  
Issued and outstanding at beginning of period (in shares) 1,156,319
Cancelled (in shares) (53,001)
Issued and outstanding at end of period (in shares) 1,097,366